Background
==========

A brief introduction of Alzheimer\'s disease
--------------------------------------------

Being the most common form of age-related dementia, Alzheimer\'s disease (AD) affects 5.4 million Americans, and at least \$183 billion will be spent in 2011 on care of AD and other dementia patients. The problem is worsening as life expectancy continues to increase. By 2050, the projected number of AD patients could range from 11 to 16 million people in the United States alone if no cure or preventive measure for AD is found. Hence, AD has quickly become a pandemic and exacted a huge socioeconomic toll \[[@B1]\].

AD is named after Dr Alois Alzheimer, who has first investigated the disease \[[@B2]\]. Later on, the autopsies of brain examinations of most cases of senility under light microscope were discovered to be extracellular deposits of β-amyloid and intracellular deposits of neurofibrillary tangles (NFTs). Abundant amounts of these lesions in the brain were necessary for a confirmed diagnosis of AD \[[@B3]\]. In 1984, an possible AD-related gene on chromosome 21 was implied when Glenner and Wong reported on the amino acid sequence of the main component of β-amyloid-, an approximate 4.3 kD peptide that they coined as \"amyloid-β protein\"(Aβ) based on their analysis of cerebrovascular amyloid derived from patients with Down\'s syndrome \[[@B4]\]. This study has laid the foundation for AD\'s \"amyloid hypothesis\" which claims that the accumulation of Aβ, as determined by its generation versus clearance in the brain, is the primary driver of AD-related pathogenesis, including neuronal cell death.

Frangione et al reported on the sequencing of the exons 16 and 17 of amyloid precursor protein (APP) to reveal the first pathogenic mutation in APP \[[@B5]\]. Finally the subsequent sequencing of these same two APP exons (encoding the Aβ portion of the molecule) that were truly linked to chromosome 21 led to the discovery of the first AD-related mutation \[[@B6]\]. Following this finding, Pericak-Vance and colleagues reported a significant genetic linkage of the more common late-onset of AD (\> 65 years) to chromosome 19 \[[@B7]\]. Then in 1993, they found a common polymorphism in the gene encoding Apolipoprotein E (APOE)- APOE allele 4, is associated with increased risk for AD \[[@B8]\]. In 1993, the first study aimed at investigating the Presenilins as putative AD genes offered evidence for a significant association between a single-nucleotide polymorphism (SNP) in intron 8 of the Presenilin 1 (PSEN1) gene and AD. Estimates were that the common variants in PSEN1 could account for nearly half of the population-attributable risk for AD than was found for the APOE4 allele \[[@B9]\]. Then in 2001, a report investigating a consecutive series of referral-based AD cases found coding sequence mutations in 11% of the samples, suggesting that PSEN1 mutations may indeed be more frequent in the general population than had been previously assumed \[[@B10],[@B11]\]. Furthermore, reports indicated that changes in the promoter region could lead to an altered expression pattern of the protein in neurons \[[@B12]\].

Currently, the mainly proposed therapeutic intervention for AD is anti-amyloid approach, which ranges from interdicting amyloidogenic processing of the β-amyloid precursor protein (APP) to removing amyloid plaques in the brain \[[@B13]\]. In addition to therapies based on curbing the production of Aβ or enhancing its clearance, another therapeutic strategy would be aimed at attenuating Aβ toxicity and neuroinflammation in the AD brain. Perhaps, the most effective way to approach the blocking of Aβ toxicity would be to prevent the formation of neurotoxic Aβ oligomers \[[@B3],[@B14]\]. As APP, the Presenilins, and APOE represent the only firmly established AD genes to date for AD, they represent the most effective means of curbing the production of Aβ or accelerating the clearance and degradation of this peptide in the brain \[[@B3]\]. The identification of the remaining genes involved in AD will enable investigators and clinicians to further delineate the path of biological events that lead to AD-related neurodegeneration \[[@B3]\].

Introduction of gene clustering and gene order
----------------------------------------------

Having been applied to many biological domains, such as drug discovery, molecular diagnosis, and toxicological research, DNA microarray technology is used most importantly to generate gene data, which holds a lot of biological information. One common data structure of a microarray data set is the presentation of a matrix. In matrix *X*, element *X~ij~*represents the expression level of the *i-th*gene in the *j-th*experiment. Then the *i-th*line vector of matrix *X*represents a group of expression levels of the *i-th*gene. The *i-th*line vector contains the biological information of the *i-th*gene, and it is often used as an atom object of data to be processed.

One important aspect of biology is to make similar genes cluster together. Since line vectors of a matrix contain the information of genes, clustering similar vectors together is equivalent to cluster similar genes together. A number of algorithms were proposed to cluster gene expression profiles. Eisen *et al*. \[[@B15]\] applied hierarchical clustering \[[@B16]\], a widely used tool \[[@B17]-[@B20]\], to solve the problem. It also has some variants \[[@B21],[@B22]\]. Self-organizing maps (SOMs) \[[@B23],[@B24]\] and k-means clustering \[[@B25]\] were also used for the same purpose. Ben-Dor *et al*. \[[@B26]\] developed an algorithm- cluster affinity search technique (CAST), that has a good theoretical basis. Merz and Zell \[[@B27]\] proposed a memetic algorithm for the problem, formulated as finding the minimum sum-of-squares clustering \[[@B28],[@B29]\].

To achieve a much better quality of clustering, the computing concept of gene order has been proposed. Gene order is the permutation of all line vectors in such a way that all the line vectors are ordered one by one in a sequence, and that similar vectors are ordered together. A gene is associated with a line vector of a matrix. The optimal gene order refers to the permutation that results in a sequence that all the vectors line up via the minimal distance. Alternatively, computing optimal gene order is equivalent to identifying a route of the traveling salesman problem (TSP) in which every vector associates with a gene that has been abstracted as a virtual city \[[@B30]-[@B35]\].

Since TSP is an NP-hard problem, the computation of the optimal gene order is NP-hard and only the approximation of the optimal gene order can be calculated. To obtain the approximation of the optimal gene order, Tsai *et al*. applied a family competition genetic algorithm (FCGA) \[[@B33]-[@B36]\] and Seung-Kyu *et al*. applied a hybrid genetic algorithm (NNGA) \[[@B37]\].

Introduction of ant colony optimization (ACO)
---------------------------------------------

First introduced in 1992, ant colony optimization (ACO) is a novel nature-inspired method based on the foraging behavior of real ants to solve TSP. (Dorigo, 1992; Dorigo *et al*., 1996, 1999; Dorigo and Stützle, 2004) \[[@B38]\]. When searching for food, ants initially explore the area surrounding their nest in a random manner. As soon as an ant finds a food source, it evaluates it and carries some food back to the nest. During the return trip, the ant deposits a pheromone trail on the ground. The pheromone deposited, the amount of which may depend on the quantity and quality of the food, guides other ants to the food source. As it has been shown (Goss *et al*., 1989), indirect communication among ants via pheromone trails enables them to find the shortest paths between their nests and food sources. ACO generates the TSP route of the highest quality in general compared with other methods. However, it is a challenge to apply ACO to calculating gene order; its running time has been too long even for input data that has less than 1000 elements when a common personal computer is used. To make ACO better suited for the computation of gene order, we have improved its running speed by factors of at least 200 \[[@B39],[@B40]\].

Introduction of genetic algorithm
---------------------------------

Genetic algorithm (GA) can be understood as an intelligent probabilistic search algorithm that works on Darwin\'s principle of natural selection and that can be applied to a variety of combinatorial optimization problems \[[@B41]\]. More to the point, GAs are based on the evolutionary process of biological organisms in nature about which theoretical foundations were originally developed by Holland \[[@B32]\]. During the course of evolution, natural populations evolve according to the principle of natural selection and \"survival of the fittest\". Individuals who are more successful in adapting to their environments will have a better chance of surviving and reproducing, whilst individuals who are less fit will be eliminated.

To understand the outline of GA as in \[[@B42]\], the following original statement is given:

A GA simulates these processes by taking an initial population of individuals and applying a genetic algorithm to their reproduction. In optimization terms, each individual in the population is encoded into a string or chromosome that represents a possible solution to a given problem. The fitness of an individual is evaluated with respect to a given objective function. Highly fit individuals or solutions have opportunities to reproduce by exchanging pieces of their genetic information, in a crossover procedure, with other highly fit individuals. This produces new \"offspring\" solutions (i.e., children), who share some characteristics taken from both parents \[[@B43]\].

To date, there are few types of tools to calculate gene order. In our knowledge, GA \[[@B35]\] and ACO \[[@B39]\] are mostly used methods. Our study intends to address this question- which method is a better for AD gene order computation using AD microarray data under different conditions. Herein, we reported that ACO fits the AD microarray data the best when calculating gene order in comparison to the GA methods tested in this study.

Methods
=======

This study intends to answer the question of which algorithm, between ACO and GA, generates the optimal AD gene order. The distance formula, which measures the similarity degree of two genes, is the key parameter that affects the quality of gene order. With different distance formulas (see the following Formulae 1-3), the gene orders will be calculated using the tools of ACO and GA in this section. Then, the quality of gene order will be measured both by the fitness function and by a heat map.

Traveling salesman problem (TSP)
--------------------------------

TSP is introduced below:

Assume that there are *n*cities and a distance matrix *D*= \[*d~ij~*\], where *d~ij~*is the distance between city *i*and city *j*, and TSP is the problem of finding a permutation *π*of all the cities such that minimizes $\sum_{i = 1}^{n - 1}d_{\pi{(i)},\pi{({i + 1})}} + d_{\pi{(n)},\pi{(1)}}$.

Measurement of gene similarity
------------------------------

As aforementioned, a gene associates with a vector and the similarity of two genes can be estimated by the distance between the two vectors.

For two genes, different metric measurements will measure out different degrees of possible similarity. That is, the estimation of gene similarity is sensitive to the distance formula.

Many distance formulas of vectors to measure the similarity of genes are presented, such as Pearson correlation, absolute correlation, Spearman rank correlation \[[@B44]\], Kendall rank correlation \[[@B45]\], and Euclidean distance. In this paper, three popular distance formulas are introduced below.

The first distance measure is the Pearson correlation:

Let k-dimensional vector *X*= (*x*~1~, *x*~2~, \..., *x*~*k*~) and *Y*= (*y*~1~, *y*~2~, \..., *y*~*k*~) be the expression levels of two genes *X*and *Y*, which are observed over a series of *k*conditions. The Pearson correlation of two genes *X*and *Y*is

$$s_{X,Y} = \frac{1}{k}\sum_{i = 1}^{k}\left( \frac{x_{i} - \overline{X}}{\sigma_{X}} \right)\left( \frac{y_{i} - \overline{Y}}{\sigma_{Y}} \right)$$

, where $\overline{X}$ and *σ~X~*is the mean and the standard deviation of the expression levels, respectively. The value of *σ~X~*is

$$\sigma_{X} = \sqrt{\frac{1}{k}\sum_{i = 1}^{k}\left( {x_{i} - \overline{X}} \right)^{2}}$$

Pearson distance is defined as

$$D_{P}\left( {X,Y} \right) = 1 - s_{X,Y}$$

The second distance is the Euclidean distance:

$$D_{E}\left( {X,Y} \right) = \sqrt{\sum_{i = 1}^{k}\left( {x_{i} - y_{i}} \right)^{2}}$$

The third distance measure is the squared Euclidean distance:

$$D_{S\textsf{E}}\left( {X,Y} \right) = \sum_{i = 1}^{k}\left( {x_{i} - y_{i}} \right)^{2}$$

Gene order
----------

As it is introduced before, a gene is associated with a vector that is derived from microarray data. In this way, a gene can be regarded as a virtual city whereby each coordinate is a vector. Two associated genes are more similar as the distance shortens between two virtual cities. As it is introduced at Section 1, an optimal (shortest) TSP route for a given set of virtual cities is the optimal gene order that is a permutation of all genes. In an optimal TSP route, closed cities are ordered together and the length of the route is that which is the shortest. In an optimal gene order, similar genes cluster together, and the quality of clustering is optimal globally. This is in contrast to many clustering methods that are only optimal locally.

Currently optimal gene order cannot be calculated perfectly because it is an NP-hard problem; only an approximation can be achieved. Therefore, we need a function to measure the quality of the approximation. The following function *Q*(*π*) is called a fitness function:

$$Q\left( \pi \right) = \sum_{i = 1}^{n}D\left( {g_{\pi_{i}},g_{\pi_{i + 1}}} \right)$$

where *g~i~*denotes a vector associated with a gene, *π*denotes a gene order, *n*is the number of genes, *D*(*g~i~*, *g*~*i*+1~) is the distance between gene *g~i~*and gene *g*~*i*+1~, and $g_{\pi_{n + 1}} = g_{\pi_{1}}$. The distance formula *D*(*g~i~*, *g*~*i*+1~) can be chosen from Pearson distance, Euclidean distance, squared Euclidean distance, Spearman distance, and other measurements.

Function *Q*(*π*) is a measurement of the quality of the gene order. The smaller the function value *Q*(*π*) is, the better the quality of the gene order *π*is.

However, the measurement of function *Q*(*π*) is not consistent with the fact of biology, and a true review of the quality of gene order depends on the review of a biologist. A biologist often reviews the quality of gene clustering by visually observing its heat map, and he or she often gets heuristic information from that heat map.

Apply ACO to calculate optimal gene order
-----------------------------------------

To generate the optimal gene order, ACO is applied as it is below:

**Step 1**: Use the distance formula to compute the distance between genes.

**Step 2**: Initialize the pheromone trails for all edges between genes (or virtual cities) and put *m*ants at different genes to travel. Pre-assign an iteration number *t*~max~and let *t*= 0, where *t*denotes the *t*- *th*iteration computation.

**Step 3**: *while*(*t*\<*t*~max~)

{

**Step 3.1:**Each ant selects its next city according to the transition probability $p_{ij}^{k}\left( t \right)$.

The transition probability of the *k*- *th*ant from the *i*- *th*gene to *j*- *th*gene is defined as

$$p_{ij}^{k}\left( t \right) = \left\{ \begin{array}{ll}
{\frac{\tau_{ij}^{\alpha}\left( t \right)\eta_{ij}^{\beta}\left( t \right)}{\sum\limits_{s \in allowed_{k}}\tau_{is}^{\alpha}\left( t \right)\eta_{is}^{\beta}\left( t \right)},} & {j \in allowed_{k}} \\
0 & {otherwise} \\
 & \\
\end{array} \right)$$

, where *allowed~k~*denotes the set of genes that can be accessed by the *k*- *th*ant; *τ~ij~*(*t*) is the pheromone value of the edge (*i, j*); *η~ij~*(*t*) is the local heuristic function and *η~ij~*(*t*) = 1/*d~ij~*, and where *d~ij~*are the distance between the *i*- *th*gene and *j*- *th*gene; the parameters α and β determine the relative influence of the trail strength and the heuristic information, respectively.

**Step 3.2**: After all ants finish their travels, all pheromone values *τ~ij~*(*t*) are updated according to the following formula.

$$\begin{matrix}
{\tau_{ij}\left( {t + 1} \right) = \left( {1 - \rho} \right) \cdot \tau_{ij}\left( t \right) + \Delta\tau_{ij}\left( t \right)} \\
{\quad\quad\quad\quad\quad\;\;\Delta\tau_{ij}\left( t \right) = \sum_{k = 1}^{m}\Delta\tau_{ij}^{k}\left( t \right)} \\
{\quad\quad\quad\quad\;\quad\mspace{9mu}\;\;\Delta\tau_{ij}^{k}\left( t \right) = \left\{ \begin{matrix}
{\frac{Q}{L_{k}},e\left( {i,j} \right) \in L_{k}} \\
{0,\begin{matrix}
 & \\
 & \\
\end{matrix}else} \\
 \\
\end{matrix} \right)} \\
 \\
\end{matrix}$$

, where *L~k~*is the length of the route passed by the *k*- *th*ant; *ρ*is the persistence of the trail; *Q*denotes constant quantity of pheromone; and *e*(*i, j*) represents the edge between gene *i*and gene *j*.

**Step 3.3**: *t*= *t*+ 1

}

**Step 4:**End procedure and select the TSP route that has the minimum length as the output.

Apply GAs to calculate optimal gene order
-----------------------------------------

As mentioned before, the calculation of gene order can be converted to TSP. To make GA fit to process TSP and gene order, the commonly used GA is modified a little. The modifications are listed below:

First, the roulette rule \[[@B46]\] is used to design selection probability.

Second, the crossover probability is set to be 1.0 in this paper. That is, the crossover will occur definitely.

Third, the mutation is designed to occur. Between the parent and mutated offspring, the one which has the better fitness value is selected as the genuine offspring, and the others are discarded.

The modified GA is described below:

**Step 1**: Initialization: Set the maximum iteration number to *t*~max~. The *t-th*iteration step is denoted by *t*. In this paper, the length of the chromosome is set to be the number of AD genes, which is denoted by *L*. The initial population is denoted by *P~old~*, and its size is set to be *N*.

**Step 2**: The next generation is denoted by *P~new~*, and it is initialized to be an empty set. In addition, a counter is used, which is denoted by *c*, and it is initialized to be 1.

**Step 3**: Selection

1\. Calculate each chromosome\'s fitness value according to formula (4).

2\. Calculate the proportion (ratio) of the fitness value of each chromosome.

3\. A ratio is chosen by the roulette rule, and its associated chromosome is chosen too. According to this method, two chromosomes are chosen, which are denoted by *C*~1~and *C*~2~.

**Step 4**: Crossover

1\. Generate two random integer numbers between 1 and *L*, which are denoted by *C*~*po*int1~and *C*~*po*int2~(*C*~*po*int1~\<*C*~*po*int2~), and where *C*~*po*int1~and *C*~*po*int2~are used to indicate the positions of two crossovers on chromosomes *C*~1~and *C*~2~.

2\. Denote the part of *C*~2~from *C*~*po*int1~to *C*~*po*int2~as *C*~*t*2~, and copy it to the head of *C*~1~. The increased chromosome *C*~1~is denoted by $C_{1}^{\prime}$.

Denote the part of *C*~1~from *C*~*po*int1~to *C*~*po*int2~as *C*~*t*1~, and copy it to the head of *C*~2~. The increased chromosome *C*~2~is denoted by $C_{2}^{\prime}$.

3\. Find every gene that lies in chromosome *C*~*t*2~and *C*~1~, which is denoted by *x*(i.e., *x*∊ *C*~*t*2~∩ *C*~1~). Delete every *x*from *C*~1~, and add *C*~*t*2~to the head of updated *C*~1~(i.e., $\left. C_{1}^{\prime}\leftarrow C_{t2} \cup \left( {C_{1} - \left\{ x \right\}} \right) \right.$). The updated $C_{1}^{\prime}$ is regarded as temporary offspring of *C*~1~and denoted as *T*~*offspring*1~. Using the same method, the temporary offspring of *C*~2~is generated, which is denoted as *T*~*offspring*2~.

**Step 5**: Mutation

Select a point on *T*~*offspring*1~randomly as a mutation point, which is denoted by *M*~*po*int1~. Suppose the value of mutation point *M*~*po*int1~is *V~old~*. Generate a random integer between 1 and *L*, which is denoted by *V~new~*. Set *V~new~*as the updated value of point *M*~*po*int1~.

Find the point at which value is equal to *V~new~*except point *M*~*po*int1~, and update its value as *V~old~*.

The chromosome *T*~*offspring*1~is updated, and it is a true offspring.

Using the above method, chromosome *T*~*offspring*2~can also be updated, and it is a true offspring.

**Step 6**: Add the two true offspring into the set *P~new~*, which represents the new population. Update the counter:

*c*= *c*+ 2, if *c*\<*N*, go to Step 3, or else go to Step 7.

**Step 7**: Joint population *P~old~*and *P~new~*(i.e., P = *P~old~*∪ *P~new~*). Select *N*chromosomes from set *P*to cover the old population *P~old~*for which the fitness values are smaller than the other chromosomes.

**Step 8**: Increase the iteration step: *t*= *t*+ 1. If *t*\<*t*~max~, and go to step 2, or else go to Step 9.

**Step 9**: End the algorithm and choose the chromosome that has the smallest fitness value from the last population *P~old~*as the output.

Kirk presented an improved GA (IGA) program \[[@B47]\], and it consists of three parts: mutation, group, and iteration.

### Part I (operation of mutation)

Suppose there is a chromosome{*a*~1~, *a*~2~, *a*~3~, *a*~4~, *a*~5~, *a*~6~}, and it is a permutation of genes *a*~1~, *a*~2~, *a*~3~, *a*~4~, *a*~5~and *a*~6~. Firstly, cut a sub-sequence from the chromosome randomly, and suppose it is {*a*~2~, *a*~3~, *a*~4~, *a*~5~}. Three types of mutations are listed below:

Flip operation *M~f~*:

Flip the gene positions of the sub-sequence. For example, $\left\{ {a_{2},a_{3},a_{4},a_{5}} \right\}\overset{M_{f}}{\rightarrow}\left\{ {a_{5},a_{4},a_{3},a_{2}} \right\}$.

Swap operation *M~s~*:

Swap the positions of the two terminal genes-$\left\{ {a_{2},a_{3},a_{4},a_{5}} \right\}\overset{M_{s}}{\rightarrow}\left\{ {a_{5},a_{3},a_{4},a_{2}} \right\}$.

Slide operation *M~l~*:

Shift the gene to the next position by a rotation-$\left\{ {a_{2},a_{3},a_{4},a_{5}} \right\}\overset{M_{l}}{\rightarrow}\left\{ {a_{3},a_{4},a_{5},a_{2}} \right\}$.

### Part II (group)

Suppose *N*chromosomes, denoted by *s*~1~, *s*~2~, *s*~3~, \..., and *s~N~*, are generated randomly where *N*is divisible by 4. And all chromosomes are saved in a table *T*sequentially. In table *T*, every 4 chromosomes is grouped as a team sequentially. For every team, perform the following operations:

Firstly, select the chromosome with the minimal fitness value as seed, and discard the other three chromosomes.

Secondly, let the mutation operation *M~f~*, *M~s~*and *M~l~*act on the seed, respectively, and generate three mutated chromosomes.

Thirdly, all chromosomes in this team are updated as the seed and the three mutated chromosomes, which updates table *T*.

### Part III (iteration computation)

An operation of a group is called an iteration computation. Within every iteration, an optimal chromosome will be generated for which the fitness value is minimal compared to the other *N*- 1 chromosomes. Suppose *R~t~*is the optimal chromosome of the *t-th*iteration. After all, iterations are performed on the set $\left\{ {R_{1},R_{2},...,R_{t_{\max}}} \right\}$ for a given number of iteration *t*~max~. The solution is selected from $\left\{ {R_{1},R_{2},...,R_{t_{\max}}} \right\}$, which has a minimal fitness value.

Source data
-----------

In this paper, the AD microarray data was downloaded from GEO Datasets, NCBI \[[@B48]\], which includes 22283 genes. Four cases of control, incipient, moderate, and severe data are provided in the original data. Nine samples of control are organized to form a matrix with a size of 22283 lines by 9 columns. The format of this matrix is shown in Table [1](#T1){ref-type="table"}. In this matrix, each line vector is a 9-dimensional vector that represents microarray data of a gene collected from nine different conditions. All line vectors form a data set.

###### 

The illustration of organization of AD microarray data

  ------------------------------------------------------------------------------------
  AFFX -NAME   GSM\    GSM\    GSM\    GSM\    GSM\    GSM\    GSM\    GSM\    GSM\
               21215   2127    2128    21219   21220   21221   21226   21231   21232
  ------------ ------- ------- ------- ------- ------- ------- ------- ------- -------
  BioB-5_at    8.937   9.941   8.986   9.305   9.366   8.781   9.236   9.35    9.386

  BioB-M_at    9.278   10.56   9.55    10.08   10.23   9.355   9.915   10.27   10.37

  BioB-3_at    7.92    9.033   8.71    8.993   9.353   8.381   8.716   9.481   9.299

  BioC-5_at    10.18   11.46   10.49   10.76   10.88   10.25   10.52   10.87   10.91
  ------------------------------------------------------------------------------------

\*Each column of the data represents the result of one microarray test. Each line of the data represents the expression levels of the same gene under different conditions. All data was log-transformed.

Seven samples of incipient for each gene are selected to form a 7-dimensional vector, and the resulting 22283 vectors are used to form a data set; eight samples of moderate for each gene are selected to form an 8-dimensional vector and to form a data set; and seven samples of severe for each gene are selected to form a data set.

In addition, according to the usual practice, all data of the AD gene is log-transformed for smoothing.

Computing parameters and environment
------------------------------------

All data tested by GAs and ACO run on a personal computer, CPU (2): 2.99 GHZ, 3.0 GHZ; Memory: 1.0 GB.

The parameters of ACO are set below:

*α*= 1, *β*= 2, *ρ*= 0.7, *Q*= 100, *τ~ij~*(0) = 1, *m*= 50, *t*~max~= 100.

The parameters of GA are set below:

*t*~max~= 500, *M*= 400,

, where *t*~max~and *M*represents the maximal number of iterations and the size of populations, respectively.

The parameters for the improved genetic algorithm are set as below:

*t*~max~= 2000, *M*= 900.

In addition, in GA, parameter values of *t*~max~and *M*are smaller than parameters in IGA, respectively. The reason that the parameter value is different is that GA is much slower than IGA, and a high value of parameter will require excessive GA program running time.

Results and discussion
======================

The results are showed in Figure [1](#F1){ref-type="fig"} to Figure [3](#F3){ref-type="fig"}, and Table [2](#T2){ref-type="table"} to Table [3](#T3){ref-type="table"}. From these figures and tables, we discovered that:

![**The comparison of the quality of gene order generated by ACO and GA using Euclidean distance**. \*Ancillary information for figures:1. All microarray data are downloaded from \[[@B48]\], and the data from the 1^st^line to 300^th^line are used to do experiment and for other figures and tables. 2. Every heat map is the optimal gene order, which has the smallest value of fitness function and was selected from tests performed over 40 times. In addition, the distance formula used in the fitness function (see formula 4) is the Euclidean Distance. 3. All of the figures listed in this paper are generated by TreeView, which was developed by Dr Eison, and is downloaded from the website: <http://rana.lbl.gov/downloads/TreeView/TreeView_vers_1_60.exe>. 4. Because most of the expression levels of the AD gene data are larger than zero, the average value of every column is subtracted when the heat map is shown. Otherwise, all heat maps are red, and the display is incorrect.](1755-8794-6-S1-S8-1){#F1}

![**The comparison of the quality of gene order generated by ACO and GA using squared Euclidean distance formula**.](1755-8794-6-S1-S8-2){#F2}

![**The comparison of the quality of gene order generated by ACO and GA using Pearson distance formula**.](1755-8794-6-S1-S8-3){#F3}

###### 

The statistical comparison of the quality of gene order

  Algorithm   Distance   Control man   Incipient patient   Moderate patient   Severe patient
  ----------- ---------- ------------- ------------------- ------------------ ----------------
  ACO         ED         507.9163      442.7255            459.7381           504.0716
  GA          ED         1800.9287     1582.5394           1689.2580          1604.3304
  IGA         ED         566.0912      508.6311            516.0917           579.3226
                                                                              
  ACO         SED        484.8221      419.8804            437.9346           479.5701
  GA          SED        1916.9891     1679.9281           1789.6030          1682.0008
  IGA         SED        576.9810      521.2992            529.8852           593.4252
                                                                              
  ACO         PD         2737.5938     2233.1848           2518.7568          2167.4011
  GA          PD         2882.9409     2532.2205           2708.5082          2515.8520
  IGA         PD         2712.5501     2319.1112           2513.9173          2218.1910

**Notation:**ED: Euclidean Distance; PD: Pearson Distance; SED: Squared Euclidean Distance

**Ancillary information:**all data in this table is the value of the fitness function, and it is the average of 40 times of tests. In addition, the distance formula used to calculate fitness value is ED. Every data in Table 5 corresponds to an average runtime.

###### 

The statistical comparison of the runtime of ACO, GA and IGA

  Algorithm   Distance   Control man   Incipient patient   Moderate patient   Severe patient
  ----------- ---------- ------------- ------------------- ------------------ ----------------
  ACO         ED         122.0545      121.8582            121.8611           121.8653
  GA          ED         580.8345      586.7355            588.9012           586.7427
  IGA         ED         133.0079      131.2152            140.4218           139.1710
                                                                              
  ACO         SED        109.8382      110.0110            109.7321           110.2532
  GA          SED        186.4143      184.5551            185.1629           185.7899
  IGA         SED        126.8957      126.9276            126.9757           127.0232
                                                                              
  ACO         PD         123.0438      122.8454            122.6719           122.6450
  GA          PD         186.9550      187.5644            187.0732           188.4089
  IGA         PD         129.8745      127.7448            127.0051           126.4476

**Notation:**ED: Euclidean Distance; PD: Pearson Distance; SED: Squared Euclidean Distance

**Ancillary Information:**Every runtime in this table is the average of 40 times of tests. In addition, every runtime corresponds to a fitness value i listed at Figure 3.

\(1\) ACO was better suited than GA to calculate the gene order of the AD genes tested in this paper.

\(2\) Both for ACO and GAs, the use of different distance formulas generated a different quality of gene order. The squared Euclidean distance generated the best quality overall compared with the Pearson distance and Euclidean distance.

Pearson distance is a popular distance formula that is commonly used to calculate gene order. However, we found that Pearson distance is not the optimal distance formula for the calculation of gene order associated with AD genes. In this paper, the original data is not normalized, the reason for which is explained below:

Suppose two genes and their associated vectors are *X*= (*x*~1~, *x*~2~, \..., *x*~*k*~) and *Y*= (*y*~1~, *y*~2~, \..., *y*~*k*~). If all components of the vector are normalized, they become small real value that is less than 1.0. Value $S = \sum_{i = 1}^{k}\left( {x_{i} - y_{i}} \right)^{2}$ is small, and it is close to zero if the two genes are very similar. Then the value of the square-root $\sqrt{S~}$ has a big error because it must be expressed as base operations (+, -, ×, and ÷) to approximate. That is why Pearson distance, Euclidean distance and other distance formulas generate lower qualities of gene order calculation compared with squared Euclidean distance.

Conclusion
==========

With AD being the most common form of senile dementia, the study of AD-associated genes is an imperative research subject. One important branch of an AD gene study is to cluster AD genes with the highest quality; gene order generates a better quality of clustering than other methods in general. In addition, our results of the experiment support the following conclusion: ACO is better than GA in AD gene order computation. Further, the following computational features were revealed in our study: For both ACO and GA, different distance formulas generated a different quality of gene order. Compared to Pearson distance and Euclidean distance, the squared Euclidean distance generated the best quality of AD gene order. Although Pearson distance commonly used tool, it is less optimal in AD gene order computation when employed in both ACO and GA methods.
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